Cis-(2,4-(dichlorophenyl)-2-(1H-1,2,4-triazol-1-yl-methyl)-1,3-dioxolan-4-yl]methyl methanesulfonate is an intermediate compound utilized in the synthesis of Itraconazole, a widely used antifungal medication. This compound serves as a pharmaceutical impurity standard for analytical purposes.
Cis-(2,4-(dichlorophenyl)-2-(1H-1,2,4-triazol-1-yl-methyl)-1,3-dioxolan-4-yl]methyl methanesulfonate is an intermediate compound utilized in the synthesis of Itraconazole, a widely used antifungal medication. This compound serves as a pharmaceutical impurity standard for analytical purposes.
Pharmaceutical
Pharmaceutical Actives & Precursors
Intermediates & Precursors
Chemical Properties & Specifications
H301: Toxic if swallowed. H315: Causes skin irritation. H319: Causes serious eye irritation.
P264: Wash hands thoroughly after handling. P270: Do not eat, drink, or smoke when using this product. P301+P310: IF SWALLOWED: Immediately call a POISON CENTER or doctor. P305+P351+P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
Serves as a reference standard in the development and quality control of Itraconazole formulations, ensuring consistency and efficacy in pharmaceutical products.
Store in a cool, dry, well-ventilated area, away from incompatible substances.
Available in various quantities; consult suppliers for specific packaging details.
CAS No. : 898543-06-1
CAS No. : 403-43-0
Category : Pharmaceutical Actives & Precursors
Sub-Category : Active Pharmaceutical Ingredients (APIs)
Description: 4-Fluorobenzoyl chloride is a key acylating agent used in organic synthesis, especially for introduc...